-
2022-501132-42-00
6
2022-08-02
Monkeypox virus disease
-
2024-513559-34-00
5
2022-07-19
Small Cell Lung Cancer (SCLC)
-
2023-509095-42-00
4
2022-07-14
Colorectal cancer
-
2024-514293-46-00
4
2022-07-07
Unresectable locally advanced or metastatic urothelial cancer
-
2024-511996-13-00
5
2022-05-11
Previously untreated, unresectable, or metastatic melanoma
-
2023-508571-37-00
4
2022-04-29
Geographic atrophy (GA) secondary to Age-related Macular Degeneration
-
2024-513229-22-00
4
2022-04-21
Advanced cutaneous melanoma and Advanced mucosal melanoma
-
2023-508828-35-01
5
2022-03-28
Patients with advanced hormone receptor-positive/HER2- negative/HER2-E
-
2024-511361-11-00
10
2022-03-25
Advanced dedifferentiated liposarcoma
-
2023-506074-12-00
5
2022-03-22
Metastatic Non-Small Cell Lung Cancer
-
2023-505457-40-00
5
2022-02-02
Previously Untreated Advanced Gastric or Gastroesophageal Junction
Can
-
2023-503571-19-00
5
2022-01-20
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-513123-17-00
5
2022-01-12
Non-infection uveitis
-
2022-502542-28-00
4
2021-12-06
Sickle Cell Disease
-
2024-512052-38-00
9
2021-12-02
Advanced triple negative breast cancer
-
2024-510762-16-00
4
2021-11-30
Metastatic head and neck squamous cell carcinoma (HNSCC)
-
2024-517251-12-00
5
2021-11-02
Recurrent or metastatic head and neck squamous cell carcinoma
-
2024-519633-35-00
6
2021-10-25
Resectable pancreatic adenocarcinoma with risk factors
-
2023-506170-12-00
4
2021-10-18
Alzheimer’s Disease
-
2023-510057-41-00
5
2021-10-06
Patients With Homozygous and Heterozygous Familial Hypercholesterolemi
-
2024-518852-22-00
3
2021-09-03
Advanced Pancreatic Cancer
-
2024-512880-30-00
5
2021-08-27
Neovascular Age-related Macular Degeneration (wet AMD)
-
2024-512227-36-00
9
2021-07-28
Advanced solid tumors
-
2023-505203-23-01
5
2021-07-26
Severe asthma with an eosinophilic phenotype